Literature DB >> 27686311

Proton pump inhibitors use; beware of side-effects.

Iftikhar Ahmad Asim Syed1, Syed Hasan Abbas Naqvi2.   

Abstract

Proton pump inhibitors are most widely prescribed medicines all over the world. Since their introduction in pharmacy, life of millions of people has changed completely. Their ability to inhibit acid secretion in stomach has changed the natural history of many once-dreaded conditions like peptic ulcer and gastroesophageal reflux disease. Operation like gastrectomy and partial gastrectomy are carried out very rarely. These medicines are considered very cost-effective, have excellent safety profile, and provide prompt symptomatic relief. However, they are not without side effects, and several warnings have been issued by the Food and Drug Agency of the United States about the risk of hypomagnesaemia, possibility of increased fracture risk, and reduction in efficacy of clopidogrel by concomitant use of proton pump inhibitors. But despite all these warnings, their use is still on the rise. This Review was planned to highlight side effects and drug interactions so that a practising physician may keep the rare but potentially devastating effects in mind while prescribing the pumps.

Entities:  

Keywords:  Proton Pump Inhibitor, Acid secretions, Histamine 2 receptor blockers, side-effects.zzm321990

Mesh:

Substances:

Year:  2016        PMID: 27686311

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  2 in total

1.  Prevalence of Micronutrient Deficiencies Prior to Bariatric Surgery: Tehran Obesity Treatment Study (TOTS).

Authors:  Golaleh Asghari; Alireza Khalaj; Maryam Ghadimi; Maryam Mahdavi; Hossein Farhadnejad; Majid Valizadeh; Fereidoun Azizi; Maryam Barzin; Farhad Hosseinpanah
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

2.  Dietary Intakes and Biochemical Parameters of Morbidly Obese Patients Prior to Bariatric Surgery.

Authors:  Mojtaba Malek; Reyhaneh Yousefi; Saeed Safari; Seyyed Hashem Sezavar Seyyedi; Azadeh Mottaghi
Journal:  Obes Surg       Date:  2019-06       Impact factor: 4.129

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.